STOCK TITAN

Amendment: Ong Yee Lung reports zero holdings in Bio Green Med (BGMS)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bio Green Med Solution, Inc. amendment to a Schedule 13G/A reports that Ong Yee Lung beneficially owns 0 shares of Common Stock, representing 0%. The filing provides the filers Malaysia citizenship and a signature dated 03/13/2026.

Positive

  • None.

Negative

  • None.

Insights

Holder amendment shows no beneficial ownership; no immediate governance impact.

Bio Green Med Solution, Inc. is listed with a Schedule 13G/A amendment by Ong Yee Lung reporting 0 shares and 0% ownership as of the filing. The amendment updates ownership disclosure without changing board or voting composition.

Cash-flow treatment and trading intent are not present in the excerpt; subsequent filings would be required to indicate any change in holdings or material governance effect.






12/31/2025

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Ong Yee Lung
Signature:/s/ Ong Yee Lung
Name/Title:Ong Yee Lung
Date:03/13/2026

Comments accompanying signature: sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-1.htm sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-2.htm sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-3.htm sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-4.htm sec.gov/Archives/edgar/data/1130166/000164117225026571/ex10-1.htm

FAQ

What does the BGMS Schedule 13G/A amendment say about ownership?

It states that Ong Yee Lung beneficially owns 0 shares of BGMS common stock, representing 0%. The form is an ownership disclosure amendment and lists the filers citizenship and address details.

Does the filing indicate any change in voting power for BGMS?

No voting power is reported; the filing shows 0 sole and 0 shared voting power. This means the filer discloses no ability to vote or direct disposition of BGMS shares.

When was the Schedule 13G/A amendment for BGMS signed?

The signature on the filing is dated 03/13/2026. The amendment is labeled Amendment No. 3 and includes references to supporting exhibit links in the signature block.

Who is the filer named on the BGMS amendment and where are they located?

The filer is Ong Yee Lung, a Malaysian citizen with a listed residence in Johor, Malaysia. The issuer's principal office address in Kuala Lumpur is included on the form.
Cyclacel Pharma

NASDAQ:CYCC

View CYCC Stock Overview

CYCC Rankings

CYCC Latest News

CYCC Latest SEC Filings

CYCC Stock Data

15.16M
774.03k
Biotechnology
Pharmaceutical Preparations
Link
Malaysia
BERKELEY HEIGHTS